|YTD NAV Return||+73.20|
|YTD Market Return||+72.82|
|Shares Outstanding||1.39 Mil|
- Last trade 5/17/2013 3:59 PM ET
|The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.|
- * Annualized returns
- Data through 4/29/2013 8:00 PM ET
|Category||Specialty - Health|
|NAME||% NET ASSETS|
|Nasdaq Biotechnology Index Swap Credit Suisse Inte||31.21%|
|Ishares Biotech (Ibb) Swap Morgan Stanley & Co. In||24.91%|
|Nasdaq Biotechnology Index Swap Merrill Lynch Inte||22.13%|
|Nasdaq Biotechnology Index Swap Ubs Ag||22.11%|
|Ishares Biotech (Ibb) Swap Merrill Lynch Internati||17.73%|
|Nasdaq Biotechnology Index Swap Societe Generale||7.35%|
|Gilead Sciences Inc||6.10%|
|Regeneron Pharmaceuticals, Inc.||5.85%|
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Quotes delayed 15min, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.